John Reed, Sanofi’s global head of R&D (Image: Endpoints News)

IL-6 to the res­cue? Sanofi, Re­gen­eron bar­rel ahead in­to an­oth­er piv­otal ef­fort test­ing Kevzara for Covid-19

Sanofi and Re­gen­eron have hus­tled up a sec­ond piv­otal tri­al for their IL-6 drug Kevzara as a po­ten­tial ther­a­py for se­vere cas­es of Covid-19. The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.